Startseite
Impressum
Datenschutz
 
 
  SPOT ON
 

Ticagrelor (BRILIQUE) for acute coronary syndrome, benefit assessment and price negotiation completed, inferences for the practice

 
  REVIEW
 

Drugs for quitting smoking II

 
  a-t READER'S QUESTIONS AND COMMENTS
 

Flupirtine (eg. KATADOLON): what´s new?

 
  QUALITY CONTROL
 

Quality comparison of prednisone tablets (DECORTIN, generics)

 
  IN BRIEF
 

Adrenaline autoinjector ANAPEN - double failure

Adrenaline autoinjectors for self-application

Liver damage - warning notice for pelargonium (UMCKALOABO)

 
  CURRENT ADR NETWORK REPORT
 

Untypical tendopathies with gyrase inhibitors

 
  SIDE EFFECTS

Sudden death with domperidone (MOTILIUM, generics)

Restriction of indications for tolperisone (MYDOCALM, generics)

Update: thromboembolism with non-oral hormonal contraceptives: vaginal ring and hormone patch

Liraglutide (VICTOZA): plea for withdrawal from the market

 
  e a-t IN INTERNET
 

Insulin glargine (LANTUS) in the ORIGIN trial: no benefit and no evidence of safety

 

© arznei-telegramm 7/2012